The David Goldfarb, MD Professor of Surgery
The Johns Hopkins University School of Medicine
Chief and Regional Director of Vascular Surgery and Endovascular Therapy
The Johns Hopkins Hospital and Johns Hopkins Medicine
Baltimore, Maryland
Presenter
SESSION 44: MORE NEW DEVELOPMENTS IN AAAS: ENDOVASCULAR TREATMENTS WITH HERITABLE AORTIC DISEASE (CONNECTIVE TISSUE GENETIC DISORDERS - CTDS): HOW DOES INTRASAC THROMBUS LOAD AFFECT AAA BEHAVIOR AND PROGNOSIS AFTER EVAR
Presenter
SESSION 47: EXCITING NEW OR REDISCOVERED TECHNIQUES, DEVICES, CONCEPTS
SESSION 44: MORE NEW DEVELOPMENTS IN AAAS: ENDOVASCULAR TREATMENTS WITH HERITABLE AORTIC DISEASE (CONNECTIVE TISSUE GENETIC DISORDERS - CTDS): HOW DOES INTRASAC THROMBUS LOAD AFFECT AAA BEHAVIOR AND PROGNOSIS AFTER EVAR
Endovascular (Endograft) Therapy For Marfan And Other CTDs: When Is It Indicated As The Primary Treatment Or After Failed Open Repair And When Is It Not: Is It Time For A Guideline Change
2:36 PM - 2:41 PM
Presenter
SESSION 47: EXCITING NEW OR REDISCOVERED TECHNIQUES, DEVICES, CONCEPTS
Current Concepts In The Treatment Of Vascular Ehlers Danlos Syndrome (EDS): How To Make Treatment Outcomes And Operations For Complications Successful: Technical Tips
7:38 AM - 7:43 AM